Suwon, South Korea

Su Young Chae

This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignee: Samsung Electronics Co., Ltd.. Active years: 2017-2020.

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 4.7

ph-index = 1


Company Filing History:


Years Active: 2017-2020

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Su Young Chae: Innovator in Bioactive Material Conjugates

Introduction

Su Young Chae is a prominent inventor based in Suwon-si, South Korea. He has made significant contributions to the field of bioactive materials, holding a total of 4 patents. His work focuses on developing innovative compounds that target specific biological pathways, which can lead to advancements in medical treatments.

Latest Patents

Among his latest patents is a c-Met targeting compound-bioactive material conjugate and its methods of use. This conjugate includes a c-Met targeting compound and a bioactive material, providing new avenues for therapeutic applications. Another notable patent is for a chemically modified targeting protein, which includes a pharmaceutical composition and methods for preparing the same. This invention aims to enhance the efficacy of drug delivery systems.

Career Highlights

Su Young Chae is currently employed at Samsung Electronics Co., Ltd., where he continues to push the boundaries of innovation in his field. His work at this leading technology company allows him to collaborate with other experts and contribute to groundbreaking research.

Collaborations

He has worked alongside talented colleagues, including Sunghyun Kim and Eun Seok Ko, who have also contributed to the advancements in their respective areas of expertise.

Conclusion

Su Young Chae's innovative work in bioactive material conjugates and targeting compounds showcases his commitment to advancing medical science. His contributions are paving the way for future developments in therapeutic applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…